The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma

CONCLUSION: The present study data supported the finding that a platinum-based combination with gemcitabine regimen initiated postoperatively significantly improved OS and CSS in patients with UTUC at stages ≥pT2 (N0-3M0). Furthermore, no survival benefit was evident in patients who started AC within 45 days after RNU compared to those who received AC within 45 to 90 days.PMID:37331821 | DOI:10.1016/j.urolonc.2023.04.025
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research